Cmed Technology has announced increased capabilities for encapsia, its advanced enterprise, cloud-based clinical data system, after increased demand for its use in decentralized trials.

Cytel’s biostatisticians have evaluated the difficulties of conducting randomized control trials in low- and middle-income countries, and have revealed the power of new, innovative statistical methods to overcome the most pressing challenges in global health research.

GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,

Optibrium Ltd and BioPharmics LLC, providers of software and computational solutions for drug discovery, have announced their partnership.

Sinocompound Catalysts Co., Ltd is sponsoring the upcoming Catalysis in the Fine Chemical Industry Conference.

InSphero AG and Hamilton have announced the companies have entered into a collaboration to improve the production and handling of 3D microtissues (spheroids).

Lonza has launched the next generation of its Nucleofector® Platform.

AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.

Pharma and biotech laboratories performing high-throughput screening, high-content screening and molecular cell biology can now benefit from a series of new automated incubators and storage solutions that offer a large capacity, fast access and wide temperature range, while helping eliminate contamination issues in high-throughput environments.

Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.